ACCP - Store - 2025 ACCP/ASHP Geriatric Pharmacy Specialty Recertification Literature Study: Module 1A-B

2025 ACCP/ASHP Geriatric Pharmacy Specialty Recertification Literature Study: Module 1A-B

Format to Purchase:

Member Price:
$65.00

Nonmember Price:
$120.00

ASHP members, please visit www.rxcertifications.org to receive member pricing.

Product Overview

The Literature Study Module provides immediate access to peer-selected, contemporary articles that are relevant to specialty practice. After learners review the content, they must successfully complete an online assessment to earn recertification credit.

Activity Overview

The Literature Study Module is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This module consists of 2 online home study activities. Each activity is designed to assess the learners’ ability to analyze and apply peer-selected contemporary articles to practice.

Module 1A: Cardiovascular
This module focuses on cardiovascular issues, including apixiban for stroke prevention, a meta-analysis of shorter antiplatelet therapy in PCI, beta blockers after MI, and tenecteplase for stroke without thrombectomy.

Module 1B: General Geriatrics
This module focuses on general geriatric issues including dupilumab for COPD, fall prevention, RSV vaccine, and resmetirom in NASH.

Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this Literature Study, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.

These activities are part of the ACCP and ASHP professional development program for BCGP recertification approved by the BPS.

Release Date: July 16, 2025
BCGP Deadline: July 14, 2026

ACPE Deadline: July 16, 2028

Publication Year: 2025
Format: Published Articles with Test for Recertification Credit
Technical Requirements:

Internet browser
Adobe Reader (available free)

Geriatric Specialty Recertification Literature Study Module 1A: Cardiovascular

Geriatric Specialty Recertification Literature Study Module 1B: General Geriatrics

*Content Matter Expert

Faculty

	Zachary Klick, Pharm.D., BCPS, BCACP, BCCP, CPP Cardiology Pharmacist/PGY2 Cardiology RPD Atrium Health Wake Forest Baptist Winston-Salem, North Carolina
	Nevena Mihalovich, Pharm.D., BCCP, BCPS Cardiology Clinical Pharmacist Atrium Health Wake Forest Baptist Medical Center Winston-Salem, North Carolina
	Dana G. Carroll, Pharm.D., BCGP, BCPS, CDES* Clinical Professor Auburn University Harrison School of Pharmacy University of Alabama Family Medicine Tuscaloosa, Alabama
	Maria Shin, Pharm.D., BCGP, BCPS* Clinical Pharmacy Specialist in Internal Medicine Robley Rex Louisville Veterans Affairs Medical Center Louisville, Kentucky

Faculty

	Teresa M. DeLellis, Pharm.D., BCPS, BCGP, AGSF Chair and Associate Professor of Pharmacy Practice Manchester University Fort Wayne, Indiana
	Julianna M. Fernandez, Pharm.D., BCPS, BCGP Clinical Associate Professor and Vice Chair of Pharmacy Practice and Translational Research University of Houston Houston, Texas
	Sum Lam, Pharm.D., BCGP, BCPS Clinical Professor St. John's University Queens, New York
	Dana G. Carroll, Pharm.D., BCGP, BCPS, CDES* Clinical Professor Auburn University Harrison School of Pharmacy University of Alabama Family Medicine Tuscaloosa, Alabama
	Lisa C. Hutchison, Pharm.D., MPH, BCGP, BCPS * Professor and Vice Chair University of Arkansas for Medical Sciences College of Pharmacy Little Rock, Arkansas

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCGP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.

Target Audience: These Literature Studies are designed to help board-certified pharmacists who are seeking recertification contact hours to maintain their Board of Pharmacy Specialties (BPS).

Geriatric Specialty Recertification Literature Study Module 1A: Cardiovascular Activity Number: 0204-9999-25-922-H01-P Contact Hour(s): 5.00 Activity Type: Application BasedLearning Objectives Module 1A: Cardiovascular This module focuses on cardiovascular issues, including apixiban for stroke prevention, a meta-analysis of shorter antiplatelet therapy in PCI, beta blockers after MI, and tenecteplase for stroke without thrombectomy. Healey JS, Lopes RD, Granger CB, et al; ARTESIA Investigators. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. N Engl J Med. 2024 Jan 11;390(2):107-117. doi: 10.1056/NEJMoa2310234. Epub 2023 Nov 12. Learning Objectives: Describe the Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Subclinical Atrial Fibrillation (ARTESIA) study by Healey and colleagues. Develop recommendations for the use of apixaban for stroke prevention in patients with subclinical atrial fibrillation who are at increased risk for stroke. Park DY, Hu JR, Jamil Y, Kelsey MD, Jones WS, Frampton J, Kochar A, Aronow WS, Damluji AA, Nanna MG. Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. JAMA Netw Open. 2024 Learning Objectives: Describe the systematic review and network meta-analysis by Park and colleagues of studies of the duration of dual antiplatelet therapy (DAPT) in older adults after percutaneous coronary intervention (PCI). Develop recommendations for the duration of dual antiplatelet therapy (DAPT) in older adults after percutaneous coronary intervention (PCI). T. Yndigegn, B. Lindahl, K. Mars, et al, for the REDUCE-AMI Investigators*, Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. N Engl J Med. 2024 Apr 18;390(15):1372-1381. Learning Objectives: Describe the Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction (REDUCE-AMI) by Yndigegn and colleagues. Develop recommendations for the use of beta-blockers in patients with acute myocardial infarction and a preserved ejection fraction. Xiong Y , Campbell BCV, Schwamm LH, et al; TRACE-III Investigators. Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy. N Engl J Med. 2024 Jul 18;391(3):203-212. doi: 10.1056/NEJMoa2402980. Epub 2024 Jun 14. Learning Objectives: Describe the Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III (TRACE-III) trial by Xiong and colleagues. Develop recommendations for the use of tenecteplase in patients with acute ischemic stroke.
Geriatric Specialty Recertification Literature Study Module 1B: General Geriatrics Activity Number: 0204-9999-25-923-H01-P Contact Hour(s): 5.00 Activity Type: Application BasedLearning Objectives Module 1B: General Geriatrics This module focuses on general geriatric issues including dupilumab for COPD, fall prevention, RSV vaccine, and resmetirom in NASH. Bhatt SP, Rabe KF, Hanania NA, et al; NOTUS Study Investigators. Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation. N Engl J Med. 2024 Jun 27;390(24):2274-2283. Learning Objectives: Describe the NOTUS study by Bhatt and colleagues of dupilumab for patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation who are at an increased risk of exacerbation. Develop recommendations for the use of dupilumab for patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation who are at an increased risk of exacerbation. Guirguis-Blake JM, Perdue LA, Coppola EL, Bean SI. Interventions to Prevent Falls in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2024 Jul 2;332(1):58-69. doi: 10.1001/jama.2024.4166. Learning Objectives: Describe the US Preventive Services Task Force (USPSTF) updated evidence report and systematic review of interventions to prevent falls in older adults. Develop recommendations for interventions to prevent falls in community-dwelling older adults. Britton A , Roper LE, Kotton CN, et al. Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Aug 15;73(32):696-702. Learning Objectives: Summarize the 2024 updated recommendations from the Advisory Committee on Immunization Practices (ACIP) for the use of respiratory syncytial virus (RSV) vaccines in adults aged ≥60 years. Develop recommendations for the use of respiratory syncytial virus (RSV) vaccines in adults aged ≥60 years. Harrison SA , Bedossa P, Guy CD, et al; MAESTRO-NASH Investigators. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. Learning Objectives: Describe the MAESTRO-NASH study by Harrison and colleagues of resmetirom for the treatment of nonalcoholic steatohepatitis (NASH) and liver fibrosis. Develop recommendations for the use of resmetirom in adults with nonalcoholic steatohepatitis (NASH) and liver fibrosis.

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.

Disclosures

Reviewers and Field Testers

2025 ACCP/ASHP Geriatric Pharmacy Specialty Recertification Literature Study: Module 1A-B

Contents

Geriatric Specialty Recertification Literature Study Module 1A: Cardiovascular

Geriatric Specialty Recertification Literature Study Module 1B: General Geriatrics

Geriatric Specialty Recertification Literature Study Module 1A: Cardiovascular

Faculty

Geriatric Specialty Recertification Literature Study Module 1B: General Geriatrics

Faculty

CPE Credit

Contents

Geriatric Specialty Recertification Literature Study Module 1A: Cardiovascular

Geriatric Specialty Recertification Literature Study Module 1B: General Geriatrics

Commercial Support

Documents Click on a document to view/download.

Cookies